Discovery and optimization of a novel series of potent mutant B-Raf V600E selective kinase inhibitors
B-Raf represents an attractive target for anticancer therapy and the development of small molecule B-Raf inhibitors has delivered new therapies for metastatic melanoma patients. We have discovered a novel class of small molecules that inhibit mutant B-Raf